Browsing by Author "Pérez López, Jorge"
Now showing items 1-4 of 4
-
Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II): a new tool for evidence-based medicine in rare diseases
Miguel-Huguet, Bernat; Pardo-Mateos, Almudena; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Moltó Abad, Marc Miquel; Pérez López, Jorge; Sampayo-Cordero, Miguel; Malfettone, Andrea (Springer Nature, 2019-10-21) -
Presenting signs and patient co‐variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED‐C) Delphi initiative
Mehta, Atul; Kuter, David J.; Salek, Sam S.; Belmatoug, Nadia; Bembi, Bruno; Bright, Jeremy; Pérez López, Jorge (Wiley, 2019-05) -
The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”
Miguel-Huguet, Bernat; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Cortés Castan, Javier; Pérez López, Jorge; Sampayo-Cordero, Miguel; Malfettone, Andrea (Frontiers Media, 2021-06-22) -
The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)
Miguel-Huguet, Bernat; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Cortés Castan, Javier; Pérez López, Jorge; Sampayo-Cordero, Miguel; Malfettone, Andrea (MDPI, 2020-09-10)